Myriad Investor Day 2023 replay is now available. Watch now

Myriad Logo
  • Patients
    • I need help with…
      • Understanding hereditary cancer riskWhat is my risk of developing hereditary cancer?
      • Treating cancerWhat are my treatment options?
      • Guiding prenatal careAm I having a boy or girl?
        • Is my baby at risk for a genetic condition?
      • Managing mental healthHow might my genes affect my medication outcomes?
    • (sidebar parent)
      • About genetic testing
        • What are the costs of genetic testing?
        • Financial assistance
      • Patient Resources
        • How does genetic testing work?
        • Patient record request
      • Prostate Cancer
        • What are my treatment options?
  • Providers
    • My patient needs a test for…
      • Assessing hereditary cancer riskWhat is my patient’s risk of developing hereditary cancer?
      • Cancer treatmentWhat is the best treatment for my patient?
      • Prenatal careWhat is the predicted fetal sex of my patient’s baby?
        • What is a pregnancy’s risk of a genetic disease?
      • Mental health treatmentHow will my patient metabolize or respond to certain medications?
    • (sidebar parent)
      • About our tests
        • Myriad test catalog
        • Research & whitepapers
        • MyRisk® gene table
        • EMR Integrations
      • Provider resources
        • Order a test
        • Order patient materials
        • Documents & forms
        • Scope of service & lab certificates
        • Provider portal
      • Prostate Cancer Treatment
        • What are my patient’s treatment options?
  • Biopharma
  • Our Tests
    • Tests for…
      • (column wrapper)
        • Prenatal care
          • Fetal sex
          • Chromosome conditions
          • Genetic diseases
        • Cancer risk assessment
          • Hereditary cancer
        • Mental health
          • Depression
          • Anxiety
          • ADHD
      • (column wrapper)
        • Cancer management
          • Breast cancer
          • Ovarian cancer
          • Pancreatic cancer
          • Prostate cancer
          • Endometrial cancer
          • Other cancers
          • All tests
    • (sidebar parent)
      • TESTS BY SPECIALTY
        • Oncology
        • Urology
        • Imaging
        • OB/GYN
        • Mental Health
        • Internal/Primary care
        • All tests
      • TESTS BY NAME
        • BRACAnalysis CDx®
        • EndoPredict®
        • Foresight®
        • GeneSight®
        • MyChoice® CDx
        • MyRisk® (cancer treatment)
        • MyRisk® (cancer risk)
        • Prequel®
        • Precise™ Tumor
        • Prolaris®
        • SneakPeek®
  • About
    • About
      • (column wrapper)
        • About Myriad
        • Leadership
        • Investor relations
      • (column wrapper)
        • Press releases
        • Careers
        • Contact
    • (sidebar parent)
      • Myriad Genetics Corporate Headquarters
        • 322 North 2200 West
        • Salt Lake City, UT 84116
        • Corporate Phone: (801) 584-3600
        • Corporate Fax: (801) 584-3640
PORTALS ORDER
    Portals
    Order
  • Patients
    • I need help with…
      • Understanding hereditary cancer riskWhat is my risk of developing hereditary cancer?
      • Treating cancerWhat are my treatment options?
      • Guiding prenatal careAm I having a boy or girl?
        • Is my baby at risk for a genetic condition?
      • Managing mental healthHow might my genes affect my medication outcomes?
    • (sidebar parent)
      • About genetic testing
        • What are the costs of genetic testing?
        • Financial assistance
      • Patient Resources
        • How does genetic testing work?
        • Patient record request
      • Prostate Cancer
        • What are my treatment options?
  • Providers
    • My patient needs a test for…
      • Assessing hereditary cancer riskWhat is my patient’s risk of developing hereditary cancer?
      • Cancer treatmentWhat is the best treatment for my patient?
      • Prenatal careWhat is the predicted fetal sex of my patient’s baby?
        • What is a pregnancy’s risk of a genetic disease?
      • Mental health treatmentHow will my patient metabolize or respond to certain medications?
    • (sidebar parent)
      • About our tests
        • Myriad test catalog
        • Research & whitepapers
        • MyRisk® gene table
        • EMR Integrations
      • Provider resources
        • Order a test
        • Order patient materials
        • Documents & forms
        • Scope of service & lab certificates
        • Provider portal
      • Prostate Cancer Treatment
        • What are my patient’s treatment options?
  • Biopharma
  • Our Tests
    • Tests for…
      • (column wrapper)
        • Prenatal care
          • Fetal sex
          • Chromosome conditions
          • Genetic diseases
        • Cancer risk assessment
          • Hereditary cancer
        • Mental health
          • Depression
          • Anxiety
          • ADHD
      • (column wrapper)
        • Cancer management
          • Breast cancer
          • Ovarian cancer
          • Pancreatic cancer
          • Prostate cancer
          • Endometrial cancer
          • Other cancers
          • All tests
    • (sidebar parent)
      • TESTS BY SPECIALTY
        • Oncology
        • Urology
        • Imaging
        • OB/GYN
        • Mental Health
        • Internal/Primary care
        • All tests
      • TESTS BY NAME
        • BRACAnalysis CDx®
        • EndoPredict®
        • Foresight®
        • GeneSight®
        • MyChoice® CDx
        • MyRisk® (cancer treatment)
        • MyRisk® (cancer risk)
        • Prequel®
        • Precise™ Tumor
        • Prolaris®
        • SneakPeek®
  • About
    • About
      • (column wrapper)
        • About Myriad
        • Leadership
        • Investor relations
      • (column wrapper)
        • Press releases
        • Careers
        • Contact
    • (sidebar parent)
      • Myriad Genetics Corporate Headquarters
        • 322 North 2200 West
        • Salt Lake City, UT 84116
        • Corporate Phone: (801) 584-3600
        • Corporate Fax: (801) 584-3640

Myriad Genetics Blog

Myriad Genetics Blog
  • Category
    • All
    • About Myriad Genetics
    • Breast Cancer
    • Carrier screening
    • Colorectal Cancer
    • Corporate
    • Diversity
    • Employee Spotlight
    • EndoPredict
    • Equity
    • GeneSight
    • Genetic Counselors
    • Gynecologic Cancer
    • Hereditary Cancer
    • Inclusion
    • Infographic for Multimedia page
    • Infographics
    • Lynch Syndrome
    • Melanoma
    • Myriad Employees
    • Myriad Science and Facilities
    • Neuroscience
    • Ovarian Cancer
    • Pancreatic Cancer
    • Patient Blog
    • Patient Story
    • Patient-Featured
    • Prenatal care
    • Prenatal Screening (NIPS)
    • Prequel
    • Prolaris
    • Prostate Cancer
    • Provider Blog
    • Uncategorized
    • Urology
    • Video
    • Women's Health

MyRisk® Patient Story: Ashley

September 29, 2023

img.attachment-full.size-full.wp-post-image {display: none;} ...

Continue Reading

Prequel® Prenatal Screen Patient Story: Naomi

September 28, 2023

img.attachment-full.size-full.wp-post-image {display: none;} ...

Continue Reading

Lisa’s story: How her mom’s battle with breast cancer inspired her to get genetic testing

September 27, 2023

I lost my mom at a young age to breast cancer. My mom was diagnosed at 43 and died at 45 – I had just turned 24 several months before. So, I always had a ...

Continue Reading

Understanding the Risks: Raising Awareness about Ovarian Cancer 

September 12, 2023

The signs of ovarian cancer can speak softly. But learning about your risks of developing ovarian cancer – and listening to your body when something doesn’...

Continue Reading

We’re Teaming Up with the March of Dimes to Support Moms and Babies

June 14, 2023

By Gwendolyn Turner, VP of Diversity, Equity & Inclusion, and Learning & Development. At Myriad Genetics, we are committed to expanding access to ge...

Continue Reading

Have You Ever Thought About the People Behind Your Lab Results? Now’s the Time!

April 27, 2023

In honor of Medical Laboratory Professionals Week, taking place April 23 to April 29 this year, we are celebrating our teammates responsible for every clinical...

Continue Reading

Healthcare Hero: Kara Cossis, Chesapeake Urology

April 12, 2023

At Myriad Genetics, our mission is to advance health and well-being for all, and a big component of that is developing reliable, accessible genetic tests for a...

Continue Reading

SGO 2023 Meeting: Reducing Health Disparities in Cancer Care

March 23, 2023

Attending scientific and clinical conferences is a great way to stay current on the latest discoveries and assures that doctors on the front lines know how Myr...

Continue Reading

Medical Experts Discuss Benefits of Genetic Testing in Prostate Cancer Care

March 23, 2023

In a recent Myriad Live webinar, our Chief Medical Officer, Thomas Slavin, hosted a lively conversation about prostate cancer with two experts from the field: ...

Continue Reading

On International Women’s Day, We’re Embracing Equity

March 7, 2023

By Marie Mount, Sr. Director, Women's Health Marketing Today is International Women’s Day! Celebrated annually on March 8 to honor the social, econo...

Continue Reading

Honoring those affected by rare diseases

February 27, 2023

Quick — name three diseases that affect humans. We bet you came up with some of the most well-known, such as heart disease, cancer, Alzheimer’s, and COVID-...

Continue Reading

New Guidelines Offer a More Equitable Approach to Carrier Screening

February 16, 2023

It’s quite common for diseases, or the risk to develop disease, to be passed down through the generations in a family. Even people who don’t have the disea...

Continue Reading

Prostate cancer can be hereditary, get peace of mind with Myriad Genetic Testing

January 13, 2023

https://myriad-1.wistia.com/medias/yff9ux0rmk When Tim Petracca was diagnosed with prostate cancer at age 63, he began to think about his extensive fa...

Continue Reading

Clinically Actionable Studies Presented at Leading Breast Cancer Conference

December 13, 2022

One of the most well-known meetings of breast cancer care experts is the annual San Antonio Breast Cancer Symposium, which takes place every December. It’s a...

Continue Reading

My Myriad: Shelly Cummings, Oncology

November 9, 2022

Here at Myriad Genetics and in recognition GC Awareness Day, we have long been committed to building the best team to help our customers and patients — and t...

Continue Reading
  • 1
  • 2
  • 3
  • 4
  • 15
  • 16
  • Managed care
    • Payers
  • Investors
    • Investor relations
  • News
    • Press releases
    • Blog
  • About
    • About Myriad
    • Careers
    • Contact us
  • Terms of Use
  • Myriad Genetics, Inc. Privacy Notice
  • HIPAA Notice of Privacy Practices
  • Patents
  • Code of Conduct
  • Supplier Code of Conduct
  • Language Assistance
  • Cookie Preferences
facebook linkedin twitter instagram youtube

Health. Illuminated.™

  • © 2023 Myriad Genetics, Inc.

Locations

United States
Europe
Japan